Zobrazeno 1 - 10
of 25
pro vyhledávání: '"H D, Bear"'
Publikováno v:
The Journal of Immunology. 148:3847-3856
We investigated the role of transforming growth factor-beta 1 (TGF-beta) in regulation of T cell growth and differentiation. Treatment of CTLL-2 cells with TGF-beta inhibited IL-2-dependent proliferation and caused morphologic changes as well as incr
Autor:
J E, Tomaszewski, H D, Bear, J A, Connally, J I, Epstein, M, Feldman, K, Foucar, L, Layfield, V, LiVolsi, R L, Sirota, M H, Stoler, R E, Stombler
Publikováno v:
American journal of clinical pathology. 114(3)
Publikováno v:
Cancer. 88(5)
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(3)
A Phase Ib trial of bryostatin 1, a macrocyclic lactone and protein kinase C (PKC) activator, was conducted in patients with refractory nonhematological malignancies with the primary goal of determining whether down-regulation of peripheral blood mon
Autor:
H D, Bear
Publikováno v:
Seminars in oncology. 25(2 Suppl 3)
Autor:
H D, Bear
Publikováno v:
Journal of surgical oncology. 67(1)
Publikováno v:
Journal of neuro-oncology. 32(1)
It has been shown that adoptive immunotherapy can be curative for established malignant tumors. The key to this treatment lies in obtaining sufficient numbers of lymphocytes which are sensitized to recognize tumor antigens and carry out immunological
Publikováno v:
Journal of neuro-oncology. 32(1)
We have investigated the anti-tumor activity of ex vivo activated and expanded T cells which had been sensitized in vivo to one of two different syngeneic rat glioma cell lines; D74 or RT-2. Rats were sensitized by inoculation of irradiated tumor cel
Publikováno v:
Seminars in surgical oncology. 12(6)
Melanoma has a somewhat unpredictable behavior, and spontaneous regressions do occasionally occur. Many have surmised that these are the result of immunologic attack by the host. Immunologic treatment has been more successful for melanoma than for mo
Publikováno v:
Leukemia. 10(7)
Based upon earlier reports of synergism in cells of lymphoid origin, we have examined interactions between the organotellurium compound AS101 and the protein kinase C (PKC) activator bryostatin 1 with respect to differentiation and Ara-C-induced apop